BXRX

Baudax Bio, Inc. Common Stock
BXRX

Overview Fund Activity
Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

28 hedge funds and large institutions have $2.78M invested in Baudax Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
3
Closed
8
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
-$146K

Top Buyers

1
AC
Armistice Capital
New York
$1.02M
2
GCP
GSA Capital Partners
United Kingdom
$152K
3
UBS Group
UBS Group
Switzerland
$41K
4
Renaissance Technologies
Renaissance Technologies
New York
$24K
5
VF
Virtu Financial
New York
$37K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
$0
2
Millennium Management
Millennium Management
New York
$16K
3
MML Investors Services
MML Investors Services
Massachusetts
$0
4
Vanguard Group
Vanguard Group
Pennsylvania
$800K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$90K -115 Closed
MML Investors Services
27
MML Investors Services
Massachusetts
– -$32K -40 Closed
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
– -$18K -23 Closed
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
– -$11K -15 Closed
LPL Financial
30
LPL Financial
California
– -$10K -12 Closed
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$7K -9 Closed
GLA
32
Good Life Advisors
Pennsylvania
– -$6K -7 Closed
1832 Asset Management
33
1832 Asset Management
Ontario, Canada
– -$1K -1 Closed
1
2